BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 16413243)

  • 21. Opioid-induced regulation of gene expression in PC12 cells stably transfected with mu-opioid receptor.
    Zarnegar P; Persson AI; Ming Y; Terenius L
    Neurosci Lett; 2006 Apr; 396(3):197-201. PubMed ID: 16377088
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The G-113A polymorphism in CYP1A2 affects the caffeine metabolic ratio in a Chinese population.
    Chen X; Wang L; Zhi L; Zhou G; Wang H; Zhang X; Hao B; Zhu Y; Cheng Z; He F
    Clin Pharmacol Ther; 2005 Sep; 78(3):249-59. PubMed ID: 16153396
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetic-epigenetic interaction modulates μ-opioid receptor regulation.
    Oertel BG; Doehring A; Roskam B; Kettner M; Hackmann N; Ferreirós N; Schmidt PH; Lötsch J
    Hum Mol Genet; 2012 Nov; 21(21):4751-60. PubMed ID: 22875838
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Relationship between paraoxonase 1 55 Met/Leu, paraoxonase 2 148 Ala/Gly genetic polymorphisms and coronary artery disease].
    Chi DS; Ling WH; Ma J; Xia M; Hou MJ; Wang Q; Zhu HL; Tang ZH; Yu XP
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2006 Jun; 23(3):289-93. PubMed ID: 16767666
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetics and pharmacodynamics of methadone enantiomers after a single oral dose of racemate.
    Boulton DW; Arnaud P; DeVane CL
    Clin Pharmacol Ther; 2001 Jul; 70(1):48-57. PubMed ID: 11452244
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of CYP2C9 amino acid polymorphisms on glyburide kinetics and on the insulin and glucose response in healthy volunteers.
    Kirchheiner J; Brockmöller J; Meineke I; Bauer S; Rohde W; Meisel C; Roots I
    Clin Pharmacol Ther; 2002 Apr; 71(4):286-96. PubMed ID: 11956512
    [TBL] [Abstract][Full Text] [Related]  

  • 27. OPRM1 genetic polymorphisms are associated with the plasma nicotine metabolite cotinine concentration in methadone maintenance patients: a cross sectional study.
    Chen YT; Tsou HH; Kuo HW; Fang CP; Wang SC; Ho IK; Chang YS; Chen CH; Hsiao CF; Wu HY; Lin KM; Chen ACh; Tsai-Wu JJ; Liu YL
    J Hum Genet; 2013 Feb; 58(2):84-90. PubMed ID: 23223006
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The A118G single nucleotide polymorphism of the mu-opioid receptor gene (OPRM1) is associated with pressure pain sensitivity in humans.
    Fillingim RB; Kaplan L; Staud R; Ness TJ; Glover TL; Campbell CM; Mogil JS; Wallace MR
    J Pain; 2005 Mar; 6(3):159-67. PubMed ID: 15772909
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of genetic polymorphisms in ABCB1, CYP2B6, OPRM1, ANKK1 and DRD2 genes on methadone therapy in Han Chinese patients.
    Hung CC; Chiou MH; Huang BH; Hsieh YW; Hsieh TJ; Huang CL; Lane HY
    Pharmacogenomics; 2011 Nov; 12(11):1525-33. PubMed ID: 21902500
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of mu-opioid receptor gene polymorphism (A118G) with variations in morphine consumption for analgesia after total knee arthroplasty.
    Chou WY; Yang LC; Lu HF; Ko JY; Wang CH; Lin SH; Lee TH; Concejero A; Hsu CJ
    Acta Anaesthesiol Scand; 2006 Aug; 50(7):787-92. PubMed ID: 16879459
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association between mu-opioid receptor-1 102T>C polymorphism and intermediate type 2 diabetes phenotypes: results from the Quebec Family Study (QFS).
    Ruchat SM; Girard M; Weisnagel SJ; Bouchard C; Vohl MC; Pérusse L
    Clin Exp Pharmacol Physiol; 2008 Sep; 35(9):1018-22. PubMed ID: 18518884
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genomic variations and transcriptional regulation of the human mu-opioid receptor gene.
    Bayerer B; Stamer U; Hoeft A; Stüber F
    Eur J Pain; 2007 May; 11(4):421-7. PubMed ID: 16843022
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetic polymorphisms in the opioid receptor mu1 gene are associated with changes in libido and insomnia in methadone maintenance patients.
    Wang SC; Tsou HH; Chen CH; Chen YT; Ho IK; Hsiao CF; Chou SY; Lin YF; Fang KC; Huang CL; Su LW; Fang YC; Liu ML; Wu HY; Lin KM; Liu SC; Kuo HW; Chiang IC; Chen AC; Tian JN; Liu YL
    Eur Neuropsychopharmacol; 2012 Oct; 22(10):695-703. PubMed ID: 22406240
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of ABCB1 (multidrug resistance transporter) gene mutations on disposition and central nervous effects of loperamide in healthy volunteers.
    Skarke C; Jarrar M; Schmidt H; Kauert G; Langer M; Geisslinger G; Lötsch J
    Pharmacogenetics; 2003 Nov; 13(11):651-60. PubMed ID: 14583678
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The differential effects of age on the association of KLOTHO gene polymorphisms with coronary artery disease.
    Rhee EJ; Oh KW; Lee WY; Kim SY; Jung CH; Kim BJ; Sung KC; Kim BS; Kang JH; Lee MH; Kim SW; Park JR
    Metabolism; 2006 Oct; 55(10):1344-51. PubMed ID: 16979405
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of alcohol or other drug dependence with alleles of the mu opioid receptor gene (OPRM1).
    Kranzler HR; Gelernter J; O'Malley S; Hernandez-Avila CA; Kaufman D
    Alcohol Clin Exp Res; 1998 Sep; 22(6):1359-62. PubMed ID: 9756053
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of dopamine and opioid receptor genetic polymorphisms with response to methadone maintenance treatment.
    Crettol S; Besson J; Croquette-Krokar M; Hämmig R; Gothuey I; Monnat M; Déglon JJ; Preisig M; Eap CB
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Oct; 32(7):1722-7. PubMed ID: 18687376
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of polymorphism in the human mu-opioid receptor OPRM1 gene with proinflammatory cytokine levels and health perception.
    Matsunaga M; Isowa T; Murakami H; Kasugai K; Yoneda M; Kaneko H; Ohira H
    Brain Behav Immun; 2009 Oct; 23(7):931-5. PubMed ID: 19341791
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acute and chronic administration of clorazepate modifies the cell surface regulation of mu opioid receptors induced by buprenorphine in specific regions of the rat brain.
    Debruyne D; Quentin T; Poisnel G; Lelong-Boulouard V; Barré L; Coquerel A
    Brain Res; 2005 Aug; 1052(2):222-31. PubMed ID: 16023087
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetics and pharmacodynamics of methadone enantiomers after coadministration with fosamprenavir-ritonavir in opioid-dependent subjects.
    Cao YJ; Smith PF; Wire MB; Lou Y; Lancaster CT; Causon RC; Bigelow GE; Martinez E; Fuchs EJ; Radebaugh C; McCabe S; Hendrix CW
    Pharmacotherapy; 2008 Jul; 28(7):863-74. PubMed ID: 18576901
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.